Status:
COMPLETED
Calcipotriol and Polymorphic Light Eruption
Lead Sponsor:
Medical University of Graz
Conditions:
Polymorphic Light Eruption
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Polymorphic light eruption (PLE) is a photodermatosis with an extremely high prevalence, particularly among young women (up to 20%). The disease is characterized through itchy skin lesions on sun-expo...
Detailed Description
PLE patients will be recruited through the Photodermatology Unit of the Department of Dermatology, Medical University of Graz, Austria. Eligible patients will be identified through diagnosis-related c...
Eligibility Criteria
Inclusion
- Diagnosis of PLE either by typical history and/or typical histology of lesions and/or positive phototesting results
- Age \> 18 years
Exclusion
- Presence of or history of malignant skin tumors
- Dysplastic melanocytic nevus syndrome
- Photosensitive diseases such as porphyria, chronic actinic dermatitis, Xeroderma pigmentosum, basal cell nevus syndrome, and others
- Autoimmune disorders such as Lupus erythematosus or dermatomyositis
- Psychiatric disorders
- Immune deficiency or systemic treatment with steroids and/or other immunosuppressive drugs
- Pregnancy or lactation
- Antinuclear antibodies
- UV exposure in test fields within 8 weeks before study start
- General poor health status
- Severe liver or renal disease, disorders or therapy of the calcium metabolism with vitamin D containing drugs
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
13 Patients enrolled
Trial Details
Trial ID
NCT00871052
Start Date
March 1 2009
End Date
May 1 2009
Last Update
October 6 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University, Department of Dermatology
Graz, Austria, A-8036